Find information on thousands of medical conditions and prescription drugs.

Amenorrhea

Amenorrhoea (BE) or amenorrhea (AmE) is the absence of a menstrual period in a woman of reproductive age. Physiologic states of amenorrhoea are seen during pregnancy and lactation (breastfeeding). Outside of the reproductive years there is absence of menses during childhood and after menopause. more...

Home
Diseases
A
Aagenaes syndrome
Aarskog Ose Pande syndrome
Aarskog syndrome
Aase Smith syndrome
Aase syndrome
ABCD syndrome
Abdallat Davis Farrage...
Abdominal aortic aneurysm
Abdominal cystic...
Abdominal defects
Ablutophobia
Absence of Gluteal muscle
Acalvaria
Acanthocheilonemiasis
Acanthocytosis
Acarophobia
Acatalasemia
Accessory pancreas
Achalasia
Achard syndrome
Achard-Thiers syndrome
Acheiropodia
Achondrogenesis
Achondrogenesis type 1A
Achondrogenesis type 1B
Achondroplasia
Achondroplastic dwarfism
Achromatopsia
Acid maltase deficiency
Ackerman syndrome
Acne
Acne rosacea
Acoustic neuroma
Acquired ichthyosis
Acquired syphilis
Acrofacial dysostosis,...
Acromegaly
Acrophobia
Acrospiroma
Actinomycosis
Activated protein C...
Acute febrile...
Acute intermittent porphyria
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Acute mountain sickness
Acute myelocytic leukemia
Acute myelogenous leukemia
Acute necrotizing...
Acute promyelocytic leukemia
Acute renal failure
Acute respiratory...
Acute tubular necrosis
Adams Nance syndrome
Adams-Oliver syndrome
Addison's disease
Adducted thumb syndrome...
Adenoid cystic carcinoma
Adenoma
Adenomyosis
Adenosine deaminase...
Adenosine monophosphate...
Adie syndrome
Adrenal incidentaloma
Adrenal insufficiency
Adrenocortical carcinoma
Adrenogenital syndrome
Adrenoleukodystrophy
Aerophobia
Agoraphobia
Agrizoophobia
Agyrophobia
Aicardi syndrome
Aichmophobia
AIDS
AIDS Dementia Complex
Ainhum
Albinism
Albright's hereditary...
Albuminurophobia
Alcaptonuria
Alcohol fetopathy
Alcoholic hepatitis
Alcoholic liver cirrhosis
Alektorophobia
Alexander disease
Alien hand syndrome
Alkaptonuria
Alliumphobia
Alopecia
Alopecia areata
Alopecia totalis
Alopecia universalis
Alpers disease
Alpha 1-antitrypsin...
Alpha-mannosidosis
Alport syndrome
Alternating hemiplegia
Alzheimer's disease
Amaurosis
Amblyopia
Ambras syndrome
Amelogenesis imperfecta
Amenorrhea
American trypanosomiasis
Amoebiasis
Amyloidosis
Amyotrophic lateral...
Anaphylaxis
Androgen insensitivity...
Anemia
Anemia, Diamond-Blackfan
Anemia, Pernicious
Anemia, Sideroblastic
Anemophobia
Anencephaly
Aneurysm
Aneurysm
Aneurysm of sinus of...
Angelman syndrome
Anguillulosis
Aniridia
Anisakiasis
Ankylosing spondylitis
Ankylostomiasis
Annular pancreas
Anorchidism
Anorexia nervosa
Anosmia
Anotia
Anthophobia
Anthrax disease
Antiphospholipid syndrome
Antisocial personality...
Antithrombin deficiency,...
Anton's syndrome
Aortic aneurysm
Aortic coarctation
Aortic dissection
Aortic valve stenosis
Apert syndrome
Aphthous stomatitis
Apiphobia
Aplastic anemia
Appendicitis
Apraxia
Arachnoiditis
Argininosuccinate...
Argininosuccinic aciduria
Argyria
Arnold-Chiari malformation
Arrhythmogenic right...
Arteriovenous malformation
Arteritis
Arthritis
Arthritis, Juvenile
Arthrogryposis
Arthrogryposis multiplex...
Asbestosis
Ascariasis
Aseptic meningitis
Asherman's syndrome
Aspartylglycosaminuria
Aspergillosis
Asphyxia neonatorum
Asthenia
Asthenia
Asthenophobia
Asthma
Astrocytoma
Ataxia telangiectasia
Atelectasis
Atelosteogenesis, type II
Atherosclerosis
Athetosis
Atopic Dermatitis
Atrial septal defect
Atrioventricular septal...
Atrophy
Attention Deficit...
Autoimmune hepatitis
Autoimmune...
Automysophobia
Autonomic dysfunction
Familial Alzheimer disease
Senescence
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Etymology and definition

The term is derived from Greek: a = negative, men = month, rhoia = flow. Derived adjectives are amenorrhoeal and amenorrheic. The opposite is the normal menstrual period.

There are two types of amenorrhoea, primary and secondary amenorrhoea. Primary amenorrhoea is the absence of menstruation in a woman by the age of 16. Also, as pubertal changes precede the first period, menarche, women who have no sign of thelarche or pubarche and thus are without evidence of iniation of puberty by the age of 14 have primary amenorrhoea. (Reference: Speroff L et al, Clinical Gynecologic Endocrinology and Infertility, 1999)

Secondary amenorrhoea is where an established menstruation has ceased for about six months or the time of three menstrual cycles.

Overview

Amenorrhoea is a symptom with many potential causes. Primary amenorrhoea may be caused by developmental problems such as the congenital absence of the uterus, or failure of the ovary to receive or maintain egg cells. Also, delay in pubertal development will lead to primary amenorrhoea. Secondary amenorrhoea is often caused by hormonal disturbances from the hypothalamus and the pituitary gland or from premature menopause, or intrauterine scar formation.

Read more at Wikipedia.org


[List your site here Free!]


Leptin eased hypothalamic amenorrhea in small trial: potential tx for infertility, anorexia nervosa
From OB/GYN News, 10/1/04 by Miriam E. Tucker

LISBON -- Recombinant human leptin appears to normalize many of the hormonal defects associated with hypothalamic amenorrhea, Dr. Christos S. Mantzoros reported at the 12th International Congress of Endocrinology.

The results of this landmark "proof of concept" study of eight women with hypothalamic amenorrhea and six controls suggest that leptin--a hormone secreted by adipocytes that regulates energy homeostasis--might represent a potential novel treatment for a range of neuroendocrine disorders, such as anorexia nervosa, infertility, and exercise-induced bone loss, said Dr. Mantzoros, director of the Human Nutrition Research Unit at Beth Israel Deaconess Medical Center, Boston.

If replicated by a placebo-controlled interventional study now underway in 80 subjects, the use of human recombinant leptin may prove preferable to current infertility treatment using pulsatile gonadotropin-releasing hormone therapy. Leptin is less expensive and better tolerated. It also improves bone density, which gonadotropin-releasing hormone does not.

"We are not at the stage of recommending treatment at this point, but I think that leptin could offer several therapeutic advantages," said Dr. Mantzoros, who is also with Harvard University.

In an open-label, prospective study that was funded by both the National Institutes of Health and Amgen, recombinant methionyl human leptin (r-metHuLeptin) was self-administered subcutaneously by eight otherwise healthy women aged 19-33 years who had secondary amenorrhea for a mean of 5.1 years due to increased exercise or low weight. None had eating disorders. The findings were published during the endocrinology congress (N. Engl. J. Med. 351[10]:987-97, 2004).

The recombinant leptin dosage was 0.08 mg/kg daily, with 40% of the total dose given at 8:00 a.m. and 60% given at 8:00 p.m. to mimic normal diurnal variation. If the patient ovulated, the study was concluded at 2 months. If not, the dose was increased to 0.2 mg/kg daily and continued for another month. Six similar women received no treatment.

During a 1-month observation period before treatment, there were no changes in treated subjects or controls in luteinizing hormone, pulsatility, body weight, ovarian variables, or hormone levels. In contrast, mean LH levels and LH pulse frequency increased in the treated subjects after 2 weeks, while maximal follicular diameter, the number of dominant follicles, ovarian volume, and estradiol levels increased over 3 months.

Three patients experienced an ovulatory menstrual cycle, and two others had preovulatory follicular development and withdrawal bleeding during treatment, Dr. Mantzoros reported.

Among other changes in the leptin-treated subjects but not the controls were increases in free triiodothyronine, free thyroxine, and insulin-like growth factor-I. Markers of bone formation (bone alkaline phosphatase and osteocalcin) increased during leptin treatment, while urinary N-telopeptides, a marker of bone resorption, did not.

Total bone density did not change during this short study, he noted.

Body weight decreased slightly in the treated subjects, due mostly to a decrease in body fat. There were no significant changes in cortisol or corticotropin levels during treatment, similar to previous findings. Subjects reported decreased appetite during the third month, but otherwise reported no adverse effects.

In an accompanying editorial, Dr. Rexford S. Ahima said that the decrease in leptin levels during fasting--which mediates the suppression of reproductive, growth, and thyroid hormones, increases glucocorticoids, and stimulates food intake--may have evolved as a defense against starvation, which hypothalamic amenorrhea closely resembles.

According to Dr. Ahima of the University of Pennsylvania, Philadelphia. "Patients with hypothalamic amenorrhea, a disease that was first described in the 1940s and was poorly understood for decades, may finally benefit from a rebirth of investigation leading to rational therapy."

BY MIRIAM E. TUCKER

Senior Writer

COPYRIGHT 2004 International Medical News Group
COPYRIGHT 2004 Gale Group

Return to Amenorrhea
Home Contact Resources Exchange Links ebay